TESARO Announces Participation at Two Investor Conferences
February 21 2017 - 4:15PM
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical
company, today announced its participation in two upcoming investor
conferences. The two conferences are:
- The Raymond James 38th Annual Institutional Investors
Conference at the JW Marriott Grand Lakes in Orlando, Florida on
Monday, March 6, 2017. Tim Pearson, EVP and CFO of TESARO,
will present at 8:40 AM ET and participate in meetings with
investors.
- The Barclays Global Healthcare Conference at the Loews
Hotel in Miami, Florida on Wednesday, March 15, 2017.
Lonnie Moulder, CEO of TESARO, will participate in an analyst-led
moderated Q&A from 3:50 to 4:15 PM ET and in meetings with
investors.
Live webcasts of the presentations at the
Raymond James and Barclays conferences will be available by
visiting the Investors section of the TESARO website at
www.tesarobio.com. Archived replays of these webcasts will be
available on the Company’s website for 14 days following the
conferences.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people bravely facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
For additional information, please contact:
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Apr 2023 to Apr 2024